Sees FY24 revenue at least $350M, consensus $370.93M. Sees FY24 $150M in Energy Industrial revenues, and $200M in Thermal Barrier revenues. Sees FY24 adjusted EBITDA $30M; net loss $23M; capital expenditures, excluding investments in Plant II, $50M. Capital expenditures for Plant II in the first half of 2024 are expected to be $30M, with an additional $15M for the second half of 2024, assuming continued construction right-timing. The Company’s 2024 outlook assumes depreciation and amortization of $30M, stock-based compensation expense of $14M, interest expense of $9M and weighted average shares outstanding of 76.5M for the full year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ASPN:
- Aspen Aerogels Projects Optimistic Financial Outlook for 2024
- Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Business Highlights
- Is ASPN a Buy, Before Earnings?
- Aspen Aerogels price target lowered to $20 from $30 at H.C. Wainwright
- Aspen Aerogels falls -9.4%
